BOSTON, MA -- June 5, 2006 -- PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced the acquisition of United Kingdom-based Clinical & Analytical Service Solutions Ltd. (C&A), a scientific equipment asset and managed maintenance company serving the pharmaceutical, biotechnology and healthcare markets. C&A, which generated revenues of approximately $7.5 million in 2005, will become an integral part of PerkinElmer’s OneSource® service products within its Laboratory Services business. OneSource consolidates all the essential laboratory equipment service needs of laboratories into a single customized solution, helping customers lower costs, dramatically increase service levels, improve productivity, simplify administration and meet the demands of regulatory compliance. Terms of the deal were not disclosed.

The acquisition, which leverages the strengths of both companies, enhances PerkinElmer’s ability to meet the needs of the estimated $2.5 billion laboratory equipment aftermarket, according to Robert F. Friel, president of PerkinElmer Life and Analytical Sciences.
“We continue to see our customers embrace the OneSource model, which enables them to realize significant cost savings through more focused management of maintenance expense and asset management, while ensuring maximum uptime for their laboratories,” explained Friel. “This strategic acquisition is a logical next step in our continued effort to help scientists keep their focus on their research results while we work on the operational front to maximize productivity, reduce costs and enhance compliance.”

Under the OneSource umbrella, managed maintenance experts joining PerkinElmer from C&A will complement PerkinElmer’s technical expertise on a broad spectrum of capabilities for a wide range of equipment platforms. Through C&A’s extensive databases of equipment maintenance solutions and performance histories, OneSource will offer customized managed maintenance solutions tailored to the requirements of each customer.

“This is a proven solution for cost reduction and increased service levels which can be used to consolidate the management of a wide portfolio of equipment models found in a typical laboratory environment into a single maintenance program,” said Ken Caskie, managing director, C&A. “Given today’s management demands for lab performance, OneSource will provide alternative options with measurable results offering the best in asset managed maintenance and technical expertise to reduce costs, enhance management information and drive improved service delivery. A truly superior product offering can now be delivered to the market.”

Factors Affecting Future Performance
This press release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities. Words such as “believes,” “intends,” “anticipates,” “plans,” “expects,” “projects,” “forecasts,” “will” and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management’s current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) our failure to introduce new products in a timely manner; (2) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses and licensed technologies into our existing business or to make them profitable; (3) our failure to protect adequately our intellectual property; (4) the loss of any of our licenses or licensed rights; (5) our ability to compete effectively; (6) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (7) our ability to produce an adequate quantity of products to meet our customers’ demands; (8) our failure to maintain compliance with applicable government regulations; (9) regulatory changes; (10) economic, political and other risks associated with foreign operations; (11) our ability to retain key personnel; (12) restrictions in our credit agreement; (13) our ability to realize the full value of our intangible assets; and (14) other factors which we describe under the caption “Risk Factors” in our most recent annual report on Form 10-K and in our most recent quarterly report on Form 10-Q and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

Other Information
Health Sciences end markets include genetic screening, environmental, service, biopharma and medical imaging. Photonics markets include sensors and specialty lighting.